Home use of mifepristone for medical abortion: a systematic review. [PDF]
Gemzell-Danielsson K +6 more
europepmc +1 more source
Abortifacient Drugs and Devices: Medical and Moral Dilemmas [PDF]
Severyn, Kristine M.
core +1 more source
A clinical care pathway for managing pregnancy in patients with inflammatory arthritis. [PDF]
Amiri N +4 more
europepmc +1 more source
Efficacy and Safety of Letrozole, Misoprostol and Their Combination in First Trimester Missed Miscarriage: <i>A randomised clinical trial</i>. [PDF]
Fikry Yousef M +10 more
europepmc +1 more source
The efficacy of mifepristone-misoprostol regimen versus misoprostol-only for medication abortion at 22 + 0/7 to 30 + 0/7 weeks' gestation. [PDF]
Touval O +5 more
europepmc +1 more source
Comparative analysis of social issues toward medical abortion using mifepristone in South Korea and the United States: Topic modeling and sentiment analysis. [PDF]
Ko M, Park DY, Oh JM, Song YK.
europepmc +1 more source
Cancer metastasis chemoprevention prevents circulating tumour cells from germination. [PDF]
Xie X, Li Y, Lian S, Lu Y, Jia L.
europepmc +1 more source
Abortion Restrictions Threaten Miscarriage Management In The United States. [PDF]
Nobles J, Hwang S, Bennett E, Jacques L.
europepmc +1 more source
Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemic. [PDF]
Chong E +17 more
europepmc +1 more source

